These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19465118)

  • 1. Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions.
    Everts V; de Vries TJ; Helfrich MH
    Biochim Biophys Acta; 2009 Aug; 1792(8):757-65. PubMed ID: 19465118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoclast diseases and dental abnormalities.
    Helfrich MH
    Arch Oral Biol; 2005 Feb; 50(2):115-22. PubMed ID: 15721137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoclast populations in congenital osteopetrosis: additional evidence of heterogeneity.
    Marks CR; Seifert MF; Marks SC
    Metab Bone Dis Relat Res; 1984; 5(5):259-64. PubMed ID: 6493038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast biology: lessons from mammalian mutations.
    Marks SC
    Am J Med Genet; 1989 Sep; 34(1):43-54. PubMed ID: 2683780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding bone cell biology requires an integrated approach: reliable opportunities to study osteoclast biology in vivo.
    Cielinski MJ; Marks SC
    J Cell Biochem; 1994 Nov; 56(3):315-22. PubMed ID: 7876324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
    Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
    Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast diseases.
    Helfrich MH
    Microsc Res Tech; 2003 Aug; 61(6):514-32. PubMed ID: 12879419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Committed osteoclast precursors colonize the bone and improve the phenotype of a mouse model of autosomal recessive osteopetrosis.
    Cappariello A; Berardi AC; Peruzzi B; Del Fattore A; Ugazio A; Bottazzo GF; Teti A
    J Bone Miner Res; 2010 Jan; 25(1):106-13. PubMed ID: 20091929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopetrosis--multiple pathways for the interception of osteoclast function.
    Marks SC
    Appl Pathol; 1987; 5(3):172-83. PubMed ID: 3304355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period.
    Boyce RW; Varela A; Chouinard L; Bussiere JL; Chellman GJ; Ominsky MS; Pyrah IT
    Bone; 2014 Jul; 64():314-25. PubMed ID: 24727159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopetrosis in the toothless rat: failure of osteoclast differentiation and function.
    Osier LK; Popoff SN; Marks SC
    Bone Miner; 1987 Oct; 3(1):35-45. PubMed ID: 3505191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hematogenous origin of osteoclasts: experimental evidence from osteopetrotic (microphthalmic) mice treated with spleen cells from beige mouse donors.
    Marks SC; Walker DG
    Am J Anat; 1981 May; 161(1):1-10. PubMed ID: 6264778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopetrosis in the rat: coexistence of reductions in osteocalcin and bone resorption.
    Lian JB; Marks SC
    Endocrinology; 1990 Feb; 126(2):955-62. PubMed ID: 2298176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental origin, functional maintenance and genetic rescue of osteoclasts.
    Jacome-Galarza CE; Percin GI; Muller JT; Mass E; Lazarov T; Eitler J; Rauner M; Yadav VK; Crozet L; Bohm M; Loyher PL; Karsenty G; Waskow C; Geissmann F
    Nature; 2019 Apr; 568(7753):541-545. PubMed ID: 30971820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclasts and odontoclasts: signaling pathways to development and disease.
    Wang Z; McCauley LK
    Oral Dis; 2011 Mar; 17(2):129-42. PubMed ID: 20659257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant osteopetrosis: a disease of abnormal osteoclast proliferation.
    Teitelbaum SL; Coccia PF; Brown DM; Kahn AJ
    Metab Bone Dis Relat Res; 1981; 3(2):99-105. PubMed ID: 7289877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of osteoclasts in a critical embryonic period is essential for inhibition of mouse tooth eruption.
    Yoshino M; Yamazaki H; Yoshida H; Niida S; Nishikawa S; Ryoke K; Kunisada T; Hayashi S
    J Bone Miner Res; 2003 Jan; 18(1):108-16. PubMed ID: 12510811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are nonresorbing osteoclasts sources of bone anabolic activity?
    Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
    J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformations of osteoclast phenotype in ia rats cured of congenital osteopetrosis.
    Marks SC; Schneider GB
    J Morphol; 1982 Nov; 174(2):141-7. PubMed ID: 7175944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.